Title : Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice.

Pub. Date : 2012 Jul 15

PMID : 22611027






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this study was to clarify the antitumor effect of vandetanib in mouse HCCs. vandetanib holocytochrome c synthetase Mus musculus
2 CONCLUSIONS: The antitumor effects of vandetanib in mice suggest that it is a potentially suitable and safe chemotherapeutic agent for HCCs. vandetanib holocytochrome c synthetase Mus musculus